Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00554320 · ClinicalTrials.gov registry record · NA

Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain

A NA study of Post Traumatic Stress Disorder and Fibromyalgia, sponsored by Summa Health System.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT00554320: Completed NA study of Post Traumatic Stress Disorder and Fibromyalgia, sponsored by Summa Health System.

NCT00554320 is a NA study of Post Traumatic Stress Disorder and Fibromyalgia that has completed, run by Summa Health System. The registered enrollment target is 24 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00554320, a NA study of Post Traumatic Stress Disorder and Fibromyalgia, has completed, sponsored by Summa Health System.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

We will rigorously test whether modulation of the motor cortex by transcranial direct current stimulation (tDCS) is an effective treatment for patients with chronic pelvic pain through the following specific aims: A) The primary aim of this study is to determine whether transcranial direct current stimulation applied to the motor cortex in patients with chronic pelvic pain induces a significant decrease in the pain or symptoms as compared with sham tDCS. We will also measure changes in the clinical symptom scores of multiple pelvic organs, drug intake (narcotic), anxiety, depression, traumatic stress, as well as overall improvement in the quality of life to assess the effects of this treatment. B) Determine the duration of the clinical effects of tDCS. We will therefore compare the amelioration of pain and related symptoms between active and sham tDCS for one year following treatment. C) Determine whether tDCS changes the threshold for pain detection as compared with sham tDCS. Patients with chronic pelvic pain have a lower threshold for pain as compared to healthy subjects and we hypothesized that this threshold will increase after stimulation with tDCS. D) Finally, we will examine whether 5 days of tDCS treatment is safe for use in chronic pelvic pain patients. Safety will be assessed through neuropsychological tests and adverse event reporting.

Interventions

  • PROCEDURE tDCS

Study Locations (1)

Ohio

  • Summa Health System - Akron

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2009-01
Est. Completion 2009-06
Phase NA
Summa Health System

13 total trials

What the finished NCT00554320 record still lists

NCT00554320 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (96% lower).

The record links to 5 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which tDCS is the first listed.

NCT00554320 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT00554320 about?

NCT00554320 is a clinical study titled "Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain". We will rigorously test whether modulation of the motor cortex by transcranial direct current stimulation (tDCS) is an effective treatment for patients with chronic pelvic pain through the following specific aims: A) The primary aim of this study is to determine whether transcranial direct current ...

What is the current status of trial NCT00554320?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2009-01. Estimated completion is 2009-06.

What conditions does trial NCT00554320 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Fibromyalgia, Irritable Bowel Syndrome, Interstitial Cystitis, Chronic Pelvic Pain.

What interventions are being tested in trial NCT00554320?

The interventions under investigation include: tDCS (PROCEDURE).

Who is sponsoring clinical trial NCT00554320?

This trial is sponsored by Summa Health System, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00554320 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00554320's enrollment target sits among peer trials

24 225th of 262 higher than 37 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00554320, the US trial registry maintained by the National Library of Medicine. NCT00554320 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.